Advertisement

Deprescription at hospital discharge: Outcomes of a deprescription promoting campaign

Published:April 18, 2017DOI:https://doi.org/10.1016/j.ejim.2017.04.008
      Deprescription is the reduction or suspension of drugs that are not necessary or which are potentially harmful — a situation found in up to 19% of all elderly European patients and in up to 46% of all institutionalized patients. The lack of time among healthcare professionals to revise previous treatments; the incorporation of electronic prescription and its tendency to perpetuate chronic treatment; and reluctance to suspend drugs prescribed by other physicians are barriers against systematic deprescription. Hospital admission offers an opportunity to consider deprescription on a proactive basis. As a complement to the article recently published in this journal [
      • Reeve E.
      • Thompson W.
      • Farrell B.
      Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action.
      ] we describe our recently reported experience [

      I. Poquet Catalá, C. Tornero Estébanez, S. Cioaia, M. Bourguet, A. Ventura Esteve, Á. Pellicer Cabo, E. Gil Tomás, M. Llopis Sanchis. Deprescripción prudente en los informes de alta hospitalaria. Resultados de una campaña de incentivación. Congreso Nacional de Medicina Interna XXXVII Congreso de la SEMI/XII Congreso de la SOMIVRAN. Zaragoza (Spain) 23–25 Noviembre 2016.

      ] with the incorporation of a deprescription promoting campaign among polymedicated patients at the time of hospital discharge.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Reeve E.
        • Thompson W.
        • Farrell B.
        Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action.
        Eur J Intern Med. 2017; 38: 3-11
      1. I. Poquet Catalá, C. Tornero Estébanez, S. Cioaia, M. Bourguet, A. Ventura Esteve, Á. Pellicer Cabo, E. Gil Tomás, M. Llopis Sanchis. Deprescripción prudente en los informes de alta hospitalaria. Resultados de una campaña de incentivación. Congreso Nacional de Medicina Interna XXXVII Congreso de la SEMI/XII Congreso de la SOMIVRAN. Zaragoza (Spain) 23–25 Noviembre 2016.

        • Garfinkel D.
        • Mangin D.
        Addressing polypharmacy: feasibility study of a systematic approach for discontinuation of multiple medications in older adults.
        Arch Intern Med. 2010; 170: 1648-1654
        • Van der Velde N.
        • Stricker B.H.
        • Pols H.A.
        • van der Cammen T.J.
        Risk of falls after withdrawal of fall-risk-increasing drugs: a prospective cohort study.
        Br J Clin Pharmacol. 2007; 63: 232-237
        • Gillespie L.D.
        • Robertson M.C.
        • Gillespie W.J.
        • Lamb S.E.
        • Gates S.
        • Cumming R.G.
        • et al.
        Interventions for preventing falls in older people living in the community.
        Cochrane Database Syst Rev. 2009; 2CD007146
        • Beer C.
        • Loh P.K.
        • Peng Y.G.
        • Potter K.
        • Millar A.
        A pilot randomized controlled trial of deprescribing.
        Ther Adv Drug Saf. 2011; 2: 37-43